Let the Pharmaceutical and Regulatory arm of Incannex do its job and you will be far better of than 20% return through litigation.....and then your up against plaintiffs with deep pockets.
Q4 will be upon us with RePosa interims and 675A data released. Plus you never know what BC has up his sleeves as more FDA hurdles are removed.
GL @Ashfield with you endeavour
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-20068
-
- There are more pages in this discussion • 374 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)